Eurobio Scientific SA (PA:ALERS) — Stock Price
Eurobio Scientific SA (PA:ALERS) is currently trading at €20.70 EUR, down 3.72% today. Over the past 52 weeks, shares have ranged between €20.00 and €25.60. This page tracks Eurobio Scientific SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Eurobio Scientific SA stock valuation.
Eurobio Scientific SA (ALERS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Eurobio Scientific SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Eurobio Scientific SA Income Statement — Revenue, Profit & Earnings by Year
Eurobio Scientific SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €154.95 Million | €130.65 Million | €152.61 Million | €184.71 Million | €188.86 Million |
| Cost of Revenue | €82.99 Million | €73.16 Million | €87.56 Million | €87.27 Million | €83.25 Million |
| Gross Profit | €71.95 Million | €57.49 Million | €65.04 Million | €97.44 Million | €105.61 Million |
| Research & Development | €4.64 Million | €8.56 Million | €3.47 Million | €3.44 Million | €1.90 Million |
| SG&A | €16.08 Million | €14.27 Million | €11.40 Million | €7.42 Million | €6.21 Million |
| Total Operating Expenses | €50.00 Million | €47.35 Million | €34.01 Million | €25.46 Million | €24.40 Million |
| Operating Income | €13.40 Million | €10.14 Million | €30.87 Million | €71.99 Million | €81.21 Million |
| EBITDA | €20.40 Million | €24.55 Million | €40.49 Million | €79.63 Million | €88.57 Million |
| EBIT | €12.00 Million | €11.40 Million | €30.97 Million | €71.77 Million | €81.56 Million |
| Interest Expense | €5.60 Million | €4.42 Million | €1.29 Million | €455.00K | €619.00K |
| Income Before Tax | €6.30 Million | €6.98 Million | €29.68 Million | €71.31 Million | €80.89 Million |
| Income Tax Expense | €2.30 Million | €2.14 Million | €4.75 Million | €10.77 Million | €7.41 Million |
| Net Income | €4.00 Million | €4.83 Million | €24.94 Million | €60.54 Million | €73.48 Million |
Eurobio Scientific SA Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Eurobio Scientific SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €257.17 Million | €316.33 Million | €330.42 Million | €209.22 Million | €172.30 Million |
| Total Current Assets | €89.59 Million | €143.91 Million | €148.37 Million | €172.95 Million | €135.21 Million |
| Cash & Equivalents | €23.07 Million | €89.03 Million | €85.94 Million | €102.39 Million | €65.56 Million |
| Short-term Investments | €1.29 Million | €39.73 Million | €38.44 Million | €9.47 Million | €456.00K |
| Net Receivables | €33.16 Million | €31.55 Million | €40.09 Million | €53.80 Million | €56.18 Million |
| Inventory | €26.92 Million | €21.45 Million | €21.65 Million | €16.29 Million | €12.93 Million |
| Property, Plant & Equipment | €12.77 Million | €12.30 Million | €12.66 Million | €10.05 Million | €9.92 Million |
| Goodwill | €118.90 Million | €117.86 Million | €115.81 Million | €18.19 Million | €20.93 Million |
| Total Liabilities | €78.31 Million | €141.16 Million | €157.75 Million | €49.00 Million | €64.45 Million |
| Total Current Liabilities | €44.15 Million | €52.88 Million | €57.32 Million | €36.11 Million | €47.98 Million |
| Long-term Debt | €27.14 Million | €81.90 Million | €95.00 Million | €7.67 Million | €11.64 Million |
| Net Debt | €12.28 Million | €52.03 Million | €66.11 Million | €-77.24 Million | €-35.40 Million |
| Total Stockholder Equity | €178.85 Million | €175.17 Million | €172.34 Million | €159.91 Million | €107.11 Million |
| Retained Earnings | €155.23 Million | €139.10 Million | €130.47 Million | €116.88 Million | €63.43 Million |
Eurobio Scientific SA Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Eurobio Scientific SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €16.70 Million | €26.77 Million | €43.07 Million | €65.92 Million | €54.93 Million |
| Capital Expenditures | €3.26 Million | €4.05 Million | €2.83 Million | €1.85 Million | €2.30 Million |
| Free Cash Flow | €13.45 Million | €22.71 Million | €39.01 Million | €63.61 Million | €52.02 Million |
| Investing Cash Flow | €-10.74 Million | €-318.00K | €-141.76 Million | €-5.47 Million | €-3.98 Million |
| Financing Cash Flow | €-72.09 Million | €-23.50 Million | €82.31 Million | €-23.75 Million | €7.67 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | €-11.10 Million | €-19.22 Million | €-41.95 Million |
| Depreciation | €17.05 Million | €13.14 Million | €9.22 Million | €7.87 Million | €7.01 Million |
| Change in Cash | €-65.96 Million | €3.09 Million | €-16.45 Million | €36.83 Million | €58.08 Million |
Eurobio Scientific SA Earnings History — EPS Actual vs. Analyst Estimates
Track Eurobio Scientific SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 27, 2026 | — | — | — |
| Oct 13, 2025 | 0.23 | 0.00 | — |
| Sep 24, 2025 | 0.23 | 0.00 | — |
| Apr 28, 2025 | 0.00 | 0.00 | — |
| Sep 24, 2024 | 0.40 | 0.00 | — |
| Apr 05, 2023 | 0.58 | — | — |
| Oct 11, 2022 | 1.86 | — | — |
| Apr 07, 2022 | 2.64 | 0.00 | — |